6 Related NICE guidance

6 Related NICE guidance

Published

Under development

NICE is developing the following guidance (details available from the NICE website):

  • Denosumab for prolonging bone metastasis-free survival in hormone-refractory prostate cancer. NICE technology appraisal guidance in development (publication expected November 2013).

  • Prostate cancer: diagnosis and treatment (update). NICE clinical guideline in development (publication expected November 2013).

  • National Institute for Health and Care Excellence (NICE)